Journal of Cachexia Sarcopenia and Muscle,
Год журнала:
2024,
Номер
15(3), С. 1146 - 1156
Опубликована: Март 27, 2024
Cachexia
is
prevalent
in
gastrointestinal
cancers
and
worsens
patient
outcomes
chemotherapy
compliance.
We
examined
to
what
extent
registered
cancer
clinical
trials
record
measures
related
symptoms
of
cachexia
as
outcomes,
whether
these
were
associated
with
trial
characteristics.
Clinical Nutrition,
Год журнала:
2024,
Номер
43(8), С. 1710 - 1718
Опубликована: Июнь 14, 2024
Malnutrition
and
sarcopenia
are
challenges
for
patients
with
metastatic
breast
cancer
have
been
proposed
as
independent
prognostic
factors.
Very
few
studies
addressed
the
temporal
evolution
of
these
parameters
and,
notably,
separate
combined
analysis
malnutrition.
This
study
aimed
to
i)
determine
prevalence
malnutrition
sarcopenia,
individually
combined,
their
over
time,
ii)
identify
risk
factors
each
condition,
iii)
explore
impact
on
overall
survival
(OS).
Nutrients,
Год журнала:
2021,
Номер
13(12), С. 4355 - 4355
Опубликована: Дек. 3, 2021
This
is
a
retrospective
study
of
data
from
clinical
practice
to
observe
the
effect
high-calorie,
high-protein
oral
nutritional
supplement
(ONS)
with
β-hydroxy-β-methylbutyrate
(HMB)
on
status,
body
weight,
and
muscle-related
parameters
in
283
adult
patients
or
at
risk
malnutrition
under
standard
care,
63%
being
cancer
patients.
They
were
recommended
increase
physical
activity
energy
protein
intake
regular
diet
plus
two
servings
per
day
specialized
ONS
enriched
HMB
for
up
6
months.
Dietary
records,
adherence
tolerance
ONS,
composition,
handgrip
strength,
blood
analysis
beginning
end
intervention
recorded.
program
improved
status
100%
malnourished
baseline
80%
well-nourished
final
visit.
It
also
increased
weight
by
3.6-3.8
kg,
fat-free
mass
0.9
1.3
strength
4.7
6.2
kg.
In
subgroup
(n
=
43),
phase
angle
(PhA),
cell
(BCM)
only
receiving
(0.95
(0.13)
vs.
-0.36
(0.4),
2.98
(0.5)
-0.6
(1.5)
mean
difference
(SE)
PhA
BCM,
respectively),
suggesting
potential
efficacy
this
muscle
health.
Cancers,
Год журнала:
2022,
Номер
14(18), С. 4402 - 4402
Опубликована: Сен. 10, 2022
Neuroendocrine
neoplasms
are
a
heterogeneous
group
of
with
increasing
incidence,
high
prevalence,
and
survival
worldwide.
About
90%
cases
well
differentiated
forms,
the
so-called
neuroendocrine
tumors
(NETs),
slow
proliferation
rates
prolonged
but
frequent
development
liver
metastases
endocrine
syndromes.
Both
tumor
itself
systemic
therapy
may
have
an
impact
on
patient
nutrition.
Malnutrition
has
negative
outcome
in
patients
NETs,
as
obesity.
In
addition,
obesity
metabolic
syndrome
been
shown
to
be
risk
factors
for
both
prognosis
NET.
Therefore,
dietary
assessment
based
body
composition
lifestyle
modifications
should
integral
part
treatment
NET
patients.
Nutrition
plans,
properly
formulated
by
dietician,
multidisciplinary
team
NETs
because
they
allow
improvement
quality
life,
providing
tailored
approach
nutritional
needs
manageable
signs
and/or
symptoms
related
pharmacological
treatment.
The
aim
this
review
is
condense
latest
evidence
role
most
used
models,
Mediterranean
diet,
ketogenic
intermittent
fasting,
context
while
considering
clinical
molecular
mechanisms
which
these
models
act.
Nutrients,
Год журнала:
2023,
Номер
15(15), С. 3391 - 3391
Опубликована: Июль 30, 2023
Cancer
cachexia
is
a
multi-organ
syndrome
with
unintentional
weight
loss,
sarcopenia,
and
systemic
inflammation.
Gastrointestinal
(GI)
cancer
patients
are
more
susceptible
to
development
due
impaired
nutrient
absorption
digestion.
Given
the
widespread
availability
relatively
low
cost
of
dietary
supplements,
we
examined
evidence
effects
fish
oil
(omega-3
fatty
acids),
melatonin,
probiotics,
green
tea
for
managing
symptoms
GI
cachexia.
A
literature
review
four
specific
supplements
was
conducted
using
PubMed,
Google
Scholar,
CINAHL
without
date
restriction.
Of
4621
available
references,
26
articles
were
eligible
review.
Fish
decreased
C-reactive
protein
maintained
CD4+
cell
count,
while
melatonin
indicated
inconsistent
findings
on
cachexia,
but
well-tolerated.
Probiotics
serum
pro-inflammatory
biomarkers
increased
tolerability
chemotherapy
by
reducing
side
effects.
Green
preparations
extracts
showed
risk
developing
various
cancers
did
not
impact
tumor
growth,
survival,
or
adverse
Among
these
probiotics
most
promising
further
research
in
preventing
inflammation
maintaining
adequate
nutrients
prevent
progression
Supplements
may
benefit
treatment
outcomes
supporting
nutritional
therapeutic
needs.
Journal of Cachexia Sarcopenia and Muscle,
Год журнала:
2024,
Номер
15(3), С. 1146 - 1156
Опубликована: Март 27, 2024
Cachexia
is
prevalent
in
gastrointestinal
cancers
and
worsens
patient
outcomes
chemotherapy
compliance.
We
examined
to
what
extent
registered
cancer
clinical
trials
record
measures
related
symptoms
of
cachexia
as
outcomes,
whether
these
were
associated
with
trial
characteristics.